Mirna Therapeutics made changes in its board of directors just recently. The biotechnology institution announced that Clay Siegall will now be one of the members of the board. Dr. Clay Siegall is the CEO of one of the most popular biotechnology company known as Seattle Genetics. In Mirna Therapeutics, Clay Siegall will serve as the outside director.
Mirna Therapeutics is a biotechnology firm that is headquartered in Texas. The pharmaceutical firm was started back in 2007, and it has been helpful to patients living with cancer. The company mostly focuses on the microRNA therapeutics. The institution has worked very hard to come up with better medications to cure cancer.
The Chief Executive Officer of Mirna Therapeutics, Dr. Paul Lammers has been very instrumental in the success the company has experienced. In a recent interview, Paul said that he was happy that Dr. Clay Siegall was joining his company. He said that he was confident that Siegall would help the company achieve its goals in advancing the microRNA therapeutics.
Dr. Clay Siegall has been in the pharmaceutical industry for a while. He has made some significant contributions in the biotechnology industry, especially in cancer treatment. In the year 2008, Dr. Clay Siegall decided to start a pharmaceutical company to help cure cancer. The company, Seattle Genetics has done quite well under his leadership.
Today, Dr. Clay Siegall serves as the CEO and president of the institution. He is also the chairman of the board of directors. His contributions have enabled the company to develop antibody therapies that help cancer patients. He has also published several books in the recent past. Dr. Clay has also helped the company to raise its capital and increase its revenue. The first product from the company has done very well in the market, and it has changed the lives of many cancer patients.
Not long ago, Seattle Genetics announced that it was planning to increase more drugs in the market. The drugs are expected to cure different types of cancers affecting people in the modern times. The company is also planning to increase the number of employees in the recent future.